Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study of the Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease

NCT01950312 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT01950312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01950312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study of the Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease
Lead sponsor
XOMA (US) LLC
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2013
Completion date
December 31, 2015
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune inner ear disease